These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 26471511)

  • 41. Depression and Oral FTC/TDF Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW).
    Defechereux PA; Mehrotra M; Liu AY; McMahan VM; Glidden DV; Mayer KH; Vargas L; Amico KR; Chodacki P; Fernandez T; Avelino-Silva VI; Burns D; Grant RM;
    AIDS Behav; 2016 Jul; 20(7):1478-88. PubMed ID: 26078115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV Antiretroviral Pre-Exposure Prophylaxis: Development Challenges and Pipeline Promise.
    Hendrix CW
    Clin Pharmacol Ther; 2018 Dec; 104(6):1082-1097. PubMed ID: 30199098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.
    Haberer JE
    Curr Opin HIV AIDS; 2016 Jan; 11(1):10-7. PubMed ID: 26633638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Effect of Depressive Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A Marginal Structural Model Analysis of The iPrEx OLE Study.
    Mehrotra ML; Glidden DV; McMahan V; Amico KR; Hosek S; Defechereux P; Mayer KH; Veloso VG; Bekker LG; Avelino-Silva VI; Schechter M; Grant RM
    AIDS Behav; 2016 Jul; 20(7):1527-34. PubMed ID: 27125241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluating the impact of prioritization of antiretroviral pre-exposure prophylaxis in New York.
    Kessler J; Myers JE; Nucifora KA; Mensah N; Toohey C; Khademi A; Cutler B; Braithwaite S
    AIDS; 2014 Nov; 28(18):2683-91. PubMed ID: 25493594
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Economic evaluation of HIV pre-exposure prophylaxis strategies: protocol for a methodological systematic review and quantitative synthesis.
    Thavorn K; Kugathasan H; Tan DHS; Moqueet N; Baral SD; Skidmore B; MacFadden D; Simkin A; Mishra S
    Syst Rev; 2018 Mar; 7(1):47. PubMed ID: 29544530
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.
    Liu AY; Hessol NA; Vittinghoff E; Amico KR; Kroboth E; Fuchs J; Irvin R; Sineath RC; Sanchez T; Sullivan PS; Buchbinder SP
    AIDS Patient Care STDS; 2014 Dec; 28(12):622-7. PubMed ID: 25396706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug Resistance During HIV Pre-Exposure Prophylaxis.
    Gibas KM; van den Berg P; Powell VE; Krakower DS
    Drugs; 2019 Apr; 79(6):609-619. PubMed ID: 30963509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of oral pre-exposure prophylaxis (PrEP) in current and future HIV prevention strategies.
    Burns DN; Grossman C; Turpin J; Elharrar V; Veronese F
    Curr HIV/AIDS Rep; 2014 Dec; 11(4):393-403. PubMed ID: 25283184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Going global: the adoption of the World Health Organization's enabling recommendation on oral pre-exposure prophylaxis for HIV.
    Hodges-Mameletzis I; Dalal S; Msimanga-Radebe B; Rodolph M; Baggaley R
    Sex Health; 2018 Nov; 15(6):489-500. PubMed ID: 30496718
    [TBL] [Abstract][Full Text] [Related]  

  • 51. From modeling to morals: imagining the future of HIV PREP in Lesotho.
    Kenworthy NJ; Bulled N
    Dev World Bioeth; 2013 Aug; 13(2):70-8. PubMed ID: 23800326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Where next with preexposure prophylaxis?
    Nugent D; Gilson R
    Curr Opin Infect Dis; 2017 Feb; 30(1):44-49. PubMed ID: 27870645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CROI 2015: Advances in HIV Testing and Prevention Strategies.
    Buchbinder SP; Liu AY
    Top Antivir Med; 2015; 23(1):8-27. PubMed ID: 25965309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. When and why women might suspend PrEP use according to perceived seasons of risk: implications for PrEP-specific risk-reduction counselling.
    Namey E; Agot K; Ahmed K; Odhiambo J; Skhosana J; Guest G; Corneli A
    Cult Health Sex; 2016 Sep; 18(9):1081-91. PubMed ID: 27093238
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV pre-exposure prophylaxis: Exploring the potential for expanding the role of pharmacists in public health.
    Okoro O; Hillman L
    J Am Pharm Assoc (2003); 2018; 58(4):412-420.e3. PubMed ID: 29789257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiretroviral pre-exposure prophylaxis implementation in the United States: a work in progress.
    Mayer KH; Hosek S; Cohen S; Liu A; Pickett J; Warren M; Krakower D; Grant R
    J Int AIDS Soc; 2015; 18(4 Suppl 3):19980. PubMed ID: 26198345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV prevention trial design in an era of effective pre-exposure prophylaxis.
    Cutrell A; Donnell D; Dunn DT; Glidden DV; Grobler A; Hanscom B; Stancil BS; Meyer RD; Wang R; Cuffe RL
    HIV Clin Trials; 2017; 18(5-6):177-188. PubMed ID: 29039265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.
    Marcus JL; Hurley LB; Hare CB; Nguyen DP; Phengrasamy T; Silverberg MJ; Stoltey JE; Volk JE
    J Acquir Immune Defic Syndr; 2016 Dec; 73(5):540-546. PubMed ID: 27851714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Challenges and opportunities for oral pre-exposure prophylaxis in the prevention of HIV infection: where are we in Europe?
    Molina JM; Pintado C; Gatey C; Ponscarme D; Charbonneau P; Loze B; Rozenbaum W; Delaugerre C
    BMC Med; 2013 Aug; 11():186. PubMed ID: 23972284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-effectiveness of oral pre-exposure prophylaxis and expanded antiretroviral therapy for preventing HIV infections in the presence of drug resistance among men who have sex with men in China: A mathematical modelling study.
    Jin X; Shi L; Wang C; Qiu T; Yin Y; Shen M; Fu G; Peng Z
    Lancet Reg Health West Pac; 2022 Jun; 23():100462. PubMed ID: 35542892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.